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Much of the justification for environmental rulemaking rests on estimates of the benefits
to society of reduced mortality rates.  Reductions in risk of death are arguably the most important
benefit underlying many of the legislative mandates in both the United States (U.S.) and Canada,
including the Safe Drinking Water Act, the Resource Conservation and Recovery Act and the
Clean Air Act in the U.S. and the Environmental Protection Act in Canada.  In two recent
analyses of the benefits of U.S. air quality legislation, for example, over 80 percent of monetized
benefits were attributed to reductions in premature mortality (USEPA 1997; USEPA 1999).
Similarly, a high proportion of monetized benefits in Canadian regulations, including Regulations
Respecting the Sulphur Content in Diesel Fuel, and Regulations Respecting the Sulphur Content
in Gasoline, are attributable to reductions in premature mortality.
Existing estimates of individuals’ willingness to pay (WTP) for mortality risk reductions,
and the implied Value of a Statistical Life (VSL), come from revealed preference studies, such as
compensating wage, consumer behavior, and stated preference studies, including those employing
contingent valuation methods.  However, the use of figures from these studies to value the lives
saved by environmental programs is problematic.  Both types of studies have focused on
measuring the value that prime-aged adults place on reducing their contemporaneous risk of
dying, whereas the majority of statistical lives saved by environmental programs, according to
epidemiological studies, appear to be the lives of older people and people with chronically
impaired health (Pope et al., 1995; Schwartz 1991; Schwartz 1993).  Furthermore, the reductions
in mortality risks brought about by environmental policies tend to be experienced with a latency
period – that is, a number of years after exposure.
It has been conjectured that older people should be willing to pay less for a reduction in
their risk of dying than younger people on the grounds that they have fewer expected life years
remaining.  Similar deductions have been made regarding the effect of health status on WTP for
mortality risk reductions.  It has been argued that people in ill health should be willing to pay less3
for a reduction in their risk of dying because their utility from an additional year of life is lower
than that of healthy people.  Alternatively, people in ill health may have higher baseline risk of
death and would therefore be willing to pay more for a given risk change.  Theory simply cannot
predict exactly how WTP varies with age or health status.  Economic theory does suggest,
however, that WTP to reduce future health risks will be less than those experienced in the present.
This theory holds even if payment for the future risk reduction is made in the present, due to
discounting and the possibility that the subject will not live to experience the future benefit.
In spite of these limitations, the USEPA currently uses a central VSL estimate, based
primarily on labor market studies, equal to approximately $6 million (1999 US$) for all ages,
citing that there is little to no empirical evidence available to support age adjustments.  In
contrast, Health Canada employs age-adjusted VSL estimates in its economic assessments,
applying a VSL of C$5 million (or US$4 million) to exposed populations under 65 years of age
and using an adjustment factor of 0.75 for populations aged 65 years and over.
1 This adjustment
factor is based on empirical estimates from Jones-Lee et al. (1985)—one of the only studies that
shows the effects of age on WTP for mortality risk reductions.  Neither agency currently makes
adjustments based on health status.
This paper provides an empirical assessment of the effects of age and baseline health on
WTP for mortality risk reductions by reporting the results of two contingent valuation surveys
designed to answer the above speculations: one conducted in Hamilton, Ontario and the other in a
nationwide survey of the U.S.  In both surveys, respondents were asked about their WTP for
several reductions in mortality risk that varied in magnitude and timing.  Two of the mortality
risk reductions were to take place over the next ten years, beginning immediately.  A third
mortality risk reduction was to take place beginning at age 70 over the course of ten years,
whereas payments to secure the risk reduction would start immediately.  WTP for immediate risk
reductions can thus be compared with WTP for future risk reductions to assess the importance of
                                                          
1 Canadian dollars are converted to U.S. dollars using a purchasing power parity of 1.25C$ per 1US$.4
the timing of the risk reduction.  In all cases, the risk reduction is delivered by an abstract, private
good (a product or action).
The questionnaire was self-administered by computer and included a probability tutorial,
questions to test probability comprehension, and debriefing questions about the acceptance of the
risk reduction scenario.  A sample of residents of Hamilton, Ontario and a nationally
representative sample of U.S. residents participated in the study.  Respondents were limited to
persons aged 40 years and older, including those older than 60, to examine the impact of age on
WTP.  We also collected extensive information about the respondent’s health status to see if it
systematically influences WTP. 
The remainder of this paper is organized as follows.  The survey instrument and its
administration are discussed in section II.  Section III presents the data, and section IV the results
of econometric estimation of models of WTP.  Section V concludes.
II. The Surveys
In both surveys, the questionnaire was self-administered on a computer, allowing us to
avoid interviewer effects and to tailor the questionnaire specifically to the respondent using
individual-specific risks and follow-up questions.  The respondents were thus able to move
through the survey at their own pace, listen to audio voice-overs, and were given extensive visual
aids to increase comprehension and subject interest. 
A. Presentation of Risks and Risk Changes
Understanding risks is essential if respondents are to report their WTP for a reduction in
mortality risks.  In our survey, respondents were given experience with graphical representations
of risks of death (depicted by colored squares on a rectangular grid) and were tested for
comprehension of probabilities before being asked WTP questions.  5
Subjects were introduced to simple probability concepts using coin tosses and roulette
wheels, working up to our standard risk communication device—a 1,000-square grid in which
risks were represented using red squares.  To test their comprehension, respondents were asked to
compare grids for two hypothetical people (person A and person B) and to determine which of the
two had the higher risk of death. They were also asked to select which of the two people they
would rather be.  The baseline risk of death for a person of the respondent’s age and gender was
then presented both numerically and graphically. 
We asked respondents to value annual risk reductions on the order of 10
-4 annually.
Changes in risk of dying were depicted in side-by-side (before and after) representations of
mortality risk, with the change in risk shown by changing the appropriate number of red squares
to blue.  We chose a risk reduction of this order of magnitude because risk changes valued in
labor market studies are typically of this size and risk reductions of comparable size are often
delivered by environmental programs (e.g., air pollution control). 
Our grid represents the chances of dying (surviving) over a 10-year period with risks on
the order of 10
-3, rather than a one-year reduction in risk of 10
-4.  The use of a 10-year period
makes it possible to represent risks using grids of 1,000 squares and to discuss risk changes of X
in 1,000.  In our questionnaire development, we found that respondents regarded grids with more
squares (e.g., 10,000 or 100,000) or denominators greater than 1,000 as confusing, and tended to
dismiss such small risk changes as insignificant.  Furthermore, respondents in focus groups more
readily accepted baseline risks and risk reductions described as occurring over longer periods,
providing another compelling reason for using the 10-year risk reduction period.
B. Introducing Income-Risk Tradeoffs
It is sometimes argued that respondents in contingent valuation surveys find it difficult to
report their WTP for a mortality risk reduction because they are not accustomed to trading off
income for reduced risks.  To mitigate this problem, we first acquainted respondents with6
quantitative risk reductions resulting from medical tests and products that were likely to be
familiar to the respondent (e.g., mammograms, colon cancer screening tests, medicine to reduce
blood pressure).  In doing so, we provided only qualitative cost information for each action and
product (“inexpensive,” “moderate” and “expensive”).
C. Willingness to Pay Questions
We asked respondents about their WTP for several reductions in their chances of dying
from their baseline risk that varied in magnitude and timing.  These included a 5-in-1,000 risk
reduction over the next 10 years, a 1-in-1,000 risk reduction over the next 10 years, and a 5-in-
1000 risk reduction beginning at age 70 from their baseline risk at age 70.  The experimental
design was the same in both countries and is shown in Table 1.
The survey was administered in each country in two waves with the only difference
between the waves being the magnitude of the risk reduction the respondent was first asked to
value.  For the risk reductions that were contemporaneous to the payments, this design allowed
the conduct of both internal and external scope tests of the WTP values.  For the 5-in-1,000 risk
reduction, it also allowed for internal scope tests on the WTP values for the contemporaneous
versus the future risk reductions. 
We argue elsewhere (Krupnick et al., forthcoming) that it is important that risk reductions
be a private good.  For this reason, the risk reduction mechanism described to respondents in our
survey was an abstract product (not covered by health insurance) that reduces each respondent’s
own risk of dying.
Regarding the timing of payments, focus groups and one-on-one interviews suggested
that payments for risk reductions should be made annually, over a ten-year period.  We use
graphs to convey the timing of the payments, as well as the relationship between the timing of
payments and the timing of the risk reductions.  This was especially important when eliciting
WTP today for a future risk reduction.7
Information about WTP was obtained through a combination of dichotomous choice
payment questions with follow-ups, and open-ended questions.  Table 2 provides the bid structure
used in the Canadian survey.  Essentially identical bids were used in the U.S. survey after
conversion to U.S. dollars using purchasing power parity.
Respondents were asked to indicate their degree of uncertainty about the WTP
respondents on a scale from 1 to 7.  Because WTP can be affected by the respondent’s
understanding of risks and interpretation of the scenario, we included debriefing questions at the
end of the questionnaire to identify respondents who had trouble comprehending the survey or
who did not accept the risk reduction being valued.
D. Administration of the Questionnaire
The Canadian survey was self-administered using the computer by a sample of 930
residents of Hamilton, Ontario.  Subjects were recruited by telephone through random-digit
Table 1. Survey Design







Wave 1 5 in 1,000 1 in 1,000 5 in 1,000
Wave 2 1 in 1,000 5 in 1,000 5 in 1,000









I 100 225 50
II 225 750 100
III 750 1100 225
IV 1100 1500 7508
dialling and asked to take the survey at a facility in downtown Hamilton.
2  The survey took place
over five months in the spring of 1999.
The respondents in the U.S. survey were reached through a technology called Web-TV©
that involves attaching a special device (resembling a cable box) to one’s television.  The user can
use a remote control device or a keyboard to access and negotiate the Internet using the TV as a
monitor.  Knowledge Networks® recruits individuals to participate as panel members in
exchange for the technology and free internet access.  The panel members are originally
contacted and recruited using telephone contacts originated through random-digit dialling, and is
representative of the U.S. population for gender, age, race and income.  Panel members are then
randomly selected to occasionally complete surveys.
3  Knowledge Networks® administered our
survey to a pre-selected sample of U.S. adults fitting our age profile in August 2000.  Of the
1,800 persons originally contacted to complete our survey, approximately 1,200 actually did so.
III. The Data 
A. Characteristics of the Respondents.
Because the U.S. and Canadian samples were recruited in different ways, it is important
to compare the characteristics of the respondents.  Table 3 shows that both samples were well
balanced in terms of gender, with only a slight prevalence of women. While the Canadian study
recruited almost exclusively whites, the U.S. sample does include blacks (11 percent) and
Hispanics (8 percent).
                                                          
2 Because of the need to travel to a centralized facility, response rates were low.  Out of 17,841 residential
phone contacts 8,260 were “cooperative,” but 4,917 households proved ineligible for age reasons.  Among
the 3,591 eligible households, 455 declined to participate because of mobility problems and 1,079 refused,
stating that the incentive payment (C$35) was insufficient.  1,545 persons agreed to participate in the
survey, but in fact only 930 (60%) kept their appointments.  All persons who began the survey completed
it, bringing our response rate to 26 percent.  The response rate is calculated as the number of respondents
successfully completing the study (930) divided by the number of eligible contacts  (3,591).
3 More information about Knowledge Networks is available from the company’s website:
www.knowledgenetworks.com.9
In part because of the differing racial compositions, the baseline risks of the respondents
are different in the two studies.  The average baseline risk is 123 in 1,000 for the Canadian
sample, and 187 in 1,000 for the U.S. sample. African Americans, included in the U.S. sample,
typically have higher baseline risks—except when very old, compared to Caucasians.   Another
difference between the two samples is inclusion of persons older than 75 years of age in the U.S.
sample.  When these African Americans and persons older than 75 years of age are excluded
from the U.S. sample, the average baseline risk for the U.S. is not statistically different from that
of the Hamilton sample.
Average household incomes are also similar, as are the years of schooling (on average,
about 13 years in both studies).  The U.S. study recruited participants from areas that are
Table 3.
Comparison across Canada and US mortality risk studies:
Characteristics of Respondents
Sample average or percent of sample
Characteristic CANADA U.S.
Male 48 percent 47 percent
Racial and Ethnic Composition:
•  African-American -- 11 percent
•  Hispanic -- 8 percent
•  White 100 percent 82 percent
Baseline risk of dying over the next 10 years:
•  Entire Sample 123 187
•  African-American -- 174
•  No African-Amer.
           Or  persons older then 75
-- 147
Household characteristics:
Annual household income (US $)
                Mean





Years of schooling 13.7 13.0
Married -- 72 percent
Household size -- 2.6
Number of adults in the household -- 2.2
Percent urban/suburban in county of
residence
100 percent 78 percent10
classified as neither urban nor suburban (22 percent of the sample), while the Canadian study, by
design, only covers residents of the urban and suburban area of Hamilton.
B. Respondent Health  
Information about respondent health status was obtained in a number of ways.  First, we
asked respondents to rate their health as excellent, very good, good, fair or poor, compared to
others the same age.  We then asked them directly whether they had been diagnosed with various
illnesses, including asthma, chronic bronchitis, emphysema, various heart ailments, cancer, high
blood pressure, and stroke.  Finally, we administered all of the questions from Short Form 36
(SF-36), a questionnaire commonly used in medical research (Ware et al., 1997).  Responses to
the SF-36 questions are summarized using index scores for physical and psychological well-being
and have been shown to correlate well with the severity of various chronic diseases (Bousquet et
al., 1994).
Table 4 displays descriptive statistics for the health status of the respondents. Because
participants in the Canada study had to be well enough to travel to a centralized facility in order
to complete the questionnaire, this sample is likely to be relatively healthy.  By contrast,
respondents in the U.S. study participated from their homes, allowing the inclusion of less healthy
individuals and persons with impaired mobility. The difference in health status across the samples
is borne out in the table.  A slightly higher percentage of respondents in the Hamilton sample
described themselves as having good or excellent health relative to others the same age (57.2
percent) compared to the U.S. sample (53.1 percent).  Furthermore, the fractions of the sample
with various types of chronic illness are slightly higher in the US.
4 While 3.4 percent of the
                                                          
4 The questions on chronic illness were asked differently across the two studies.  Canadian respondents
were asked, in one single question, to indicate whether they were ever diagnosed with one of the following
illness: asthma, bronchitis, or emphysema.  Respondents in the U.S. study, however, were asked to indicate
whether they had ever been diagnosed with each of the following illnesses in four distinct questions (i)
asthma, (ii) chronic bronchitis, (iii) emphysema, or (iv) other respiratory illnesses. Similarly, the
respondents in Hamilton were asked if they had been diagnosed with heart disease, whereas the subjects in
the U.S. study were asked four specific questions—whether they had ever been diagnosed with (i) angina
pectoris, (ii) coronary disease, (iii) other heart disease, and (iv) whether they had ever had a heart attack.11
Hamilton respondents said that they had or had had cancer (a figure that is in line with the area’s
official health statistics), 11 percent of the U.S. study reported to have been diagnosed with
cancer.  Of the latter, about 80 percent were receiving or had received treatment.  Despite these
differences in self-reported illness, the health index scores created using the responses to the SF-
36 questions are very similar. 
C. Probability Comprehension and Acceptance of the Scenario.
Valuing mortality risk reductions through direct questioning techniques requires that the
subjects understand risks.  To test their comprehension of probabilities, we asked our respondents
several questions relying on side-by-side grids of squares to convey the chances of dying for two
people -- person A and person B – as noted earlier.  The first question, which we refer to as the
probability test question, asks simply which of the two people has the higher probability of dying.
The second question, the probability choice question, asks which of the two people the
Table 4.
Comparison of Respondent Health Status Across the Canada and U.S. Studies
Sample mean or percent
Health Condition CANADA US
Has asthma 10 %
Has bronchitis 7 %*
Has emphysema
14 % 16 %
4 %
Has angina pectoris 8 %






Has had a stroke -- 4 %
Has been diagnosed with cancer 3 % 11 %
General health score from SF-36 70 67
Physical functioning score from SF-36 81 78
Vitality score from SF-36 63 59
Role-emotional score from SF-36 81 87
Mental health score from SF-36 76 77
Rates own health as good or excellent, relative to
others of the same age
57 % 53 %
* chronic bronchitis12
respondent would rather be.  If respondents answer the probability test question incorrectly,
another brief explanation of the concept is provided and the respondent is asked a second
probability test question.  Furthermore, should respondents indicate a preference for the person
with the higher risk in the choice question, they are asked to confirm their selection following
another brief explanation of grids.  
Table 5 reports the results of the probability test and choice questions as well as other
indicators of probability comprehension.  The table shows that roughly 12 percent of the
respondents answered the initial probability test incorrectly.  However, following the brief
explanation of the error, a much smaller portion provided an incorrect answer to the second
probability test (1.1 percent in Canada and 1.8 percent in the U.S.).  Likewise, a similar
proportion initially indicated a preference for the person with the higher risk in the probability
choice question (11 percent in the U.S. and 13 percent in Canada).  However, most of these
respondents, as before, corrected their answer when prompted, with only 1.3 percent of the
samples confirming that they would prefer to be the person with the higher risk of death.
Table 5.
Comparison across Canada and U.S. Mortality Risk Studies:
Probability Comprehension
Percent of the sample
CANADA U.S.
Probability test questions answered incorrectly:
•  1
st probability test question 11.6 12.2
•  2
nd probability test question  (FLAG 4) 1.1 1.8
Indicates preference for individual with higher risk of death in:
•  1
st probability choice question 13.0 10.8
•  Follow-up “confirmation” question
(FLAG5)
1.3 1.3
Other indicators of probability comprehension:
•  Fails both probability test and  choice
questions (FLAG1)
2.6 3.7
•  Claims to understand probability
poorly (FLAG6)
7.0 16.213
Combining the responses to the test and choice questions, around three percent of each
sample answered the initial probability test question incorrectly and indicated a preference for the
person with the higher chance of dying in the probability choice question.  Interestingly, most of
these respondents were among those who admitted having a poor understanding of the concept of
probability in debriefing questions at the end of the survey. Notably, the fraction of the sample
that so assessed their comprehension of probabilities is more than twice as large in the U.S. study
as in the Canada study.
In table 6 we examine the acceptance of the risk-reducing product/action and the scenario
presented in the questionnaire.  Roughly 20 to 25 percent of the respondents did not believe the
baseline risk figures that were presented to them.  Most of the respondents who disputed such
figures thought that their own risks of death were lower than the questionnaire stated.
Approximately one-third of the respondents in each sample had doubts about the effectiveness of
the product/action with a large fraction of these respondents stating that these doubts influenced
their WTP for the product/action itself. 
Furthermore, a larger proportion of the Hamilton respondents voiced concern about
possible side effects of the product/action compared to the U.S. sample (25 percent and 15
percent respectively), and admitted thinking about other benefits of the product (49 percent versus
37 percent).  In the U.S. study, respondents were probed further about the kinds of additional
benefits they had in mind.  Other benefits for these respondents included additional benefits to
themselves (40 percent), benefits to other people—such as family members—of their living
longer (25 percent) and improved health for other people (26 percent).
In Hamilton, 26 percent of the respondents noted that they did not consider whether they
could afford the product/action when answering the payment question.  In the U.S., the fraction of
the sample reporting such a behavior was even higher (37 percent).  As discussed in Krupnick et
al. (forthcoming), these responses were common among people that were not willing to pay
anything for the product.  We conclude that most of these respondents had already ruled out the14
purchase the product/action making the price irrelevant to their decision.  Finally, about 14
percent of the respondents revealed that they had not understood that they would be required to
make a payment every year for 10 years in order to receive the product and secure its risk-
reducing benefits.
IV. Willingness to Pay Results 
A. Responses to the payment questions and WTP figures
For each risk reduction to be valued, respondents were asked a minimum of two
questions.  Respondents were asked an initial dichotomous choice question querying them about a
dollar amount randomly chosen from four pre-determined values (see Table 2).  Those
respondents who answered in the affirmative were queried about their willingness to pay a higher
dollar amount, while those who declined were given a lower dollar amount.  A final open-ended
question was asked of those respondents who gave “yes-yes” or “no-no” responses.  The structure
of the payment question is shown in Figure 1.
Table 6. Comparison across Canada and US studies:
Acceptance of the Product and Scenario
Percent of the sample
CANADA US
Did not believe the risk figures (FLAG7) 19.7 24.5
•  Thought own risks were higher 15.9* 20.5*
•  Thought own risks were lower 84.1* 79.5*
Doubts effectiveness of the product /action (FLAG8) 30.6 33.5
•  Doubts about effectiveness influenced WTP (FLAG9) 19.7 21.1
Thought about possible side effects of the product
(FLAG10)
25.0 15.4
Thought of other benefits of the product (FLAG11) 48.7 36.6
•  Other benefits to self -- 39.7**
•  Benefits to other people of living longer -- 25.2**
•  Improved health for other  people -- 25.7**
Did not consider whether he could afford the
product/action (FLAG15)
26.0 37.4
Did not understand the timing of the payments (FLAG16) 13.0 14.0
* Percent of the respondents who did not believe the risk figures;
** Percent of the respondents who thought of other benefits of the product.15
Figure 1:  Structure of Payment Questions1617
As is often the case with this type of valuation approach, a relatively high proportion of
respondents in both samples indicated that they were not willing to pay anything for the
product/action we described.  Using probit models, we attempted to identify determinants of the
zero WTP responses. In the right-hand side of our probit equations, we included variables known
to influence baseline risks, including the respondent’s gender, age, and race (for the U.S. study
only), as well as income, and education.   We also included dummy variables capturing
perceptions of the risk figures and interpretations of the risk-reducing scenario, in addition to
other variables measuring health status.  
In short, we found that very few of these variables had significant coefficients.
Specifically, we found that our Canadian subjects were significantly more likely to have zero
WTP if they also reported that they did not consider whether or not they could afford the payment
when responding to the payment questions. Interestingly, Canadian respondents with high mental
health scores from SF-36 were significantly less likely to have zero WTP.  Because high mental
health scores imply respondents with less psychological distress, we interpreted this finding as
consistent with the notion that increasing one’s chance of survival is highly valued when one has
a rosier view of life. We were, therefore, surprised to find that, in our U.S. study, high mental
health scores related positively to the likelihood of having zero WTP for a given risk reduction.
U.S. males were also more likely to indicate zero WTP.  Again, those respondents who also said
they did not consider whether they could afford the payments were more likely to report zero
willingness to pay.
Before we estimate a statistical model of WTP, it is important to establish criteria that the
WTP responses must satisfy for consistency with economic theory. We use three such criteria.
First, the percentage of respondents answering “yes” to the initial payment question must decline
with the dollar amount presented to the respondents.  Second, respondents should be willing to
pay more for a larger risk reduction.  Third, under certain assumptions willingness to pay should
be near-proportional to the size of the risk reduction.  To check if the first criterion is met, we use18
only the responses to the initial payment question.  For the second and third requirements, on the
other hand, we utilize the responses to the initial payment questions as well as the subsequent
round of follow-ups, fit a formal statistical model of WTP, and use the latter to produce estimates
of mean WTP for the specified risk reductions.
5  
Our statistical model is an interval-data model based on the Weibull distribution, and is
estimated using the method of maximum likelihood.  The log likelihood function of the responses
is:
[] ∑ − =
i
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interval around the respondent’s WTP amount.
Figures 2 and 3 show clearly that the first requirement is easily met in both the Canada
and U.S. studies: the percentage of “yes” responses clearly declines with the bid amounts used for
the initial payment questions.  For the 5 in 1,000 risk reduction (wave 1), around 73 percent of the
respondents are willing to pay the lowest bid amounts used (C$100 in the Hamilton study and $70
in the U.S. study).  Comparatively smaller proportions are willing to pay the highest bid amounts
(26 percent in Canada and 35 percent in the U.S.).  A similar reaction to the 1 in 1,000 risk
reduction (wave 2) is also found in both countries.  The fraction of the sample willing to pay for
the 1 in 1,000 risk reduction declines from 49 percent (for C$100) to 20 percent (C$1100) in
Canada, and from 44 percent (for $70) to 13 percent ($725) in the U.S. 
Furthermore, the percentages of respondents willing to pay for the 1 in 1,000 risk
reduction are smaller than those for the 5 in 1,000 risk reduction at all bid levels. We therefore
                                                          
5 In this paper, we therefore elect not to use the responses to the open-ended questions.  In Canada, 19.5
and 36.8 percent of the respondents indicated that they were not willing to pay anything at all for the 5 in
1,000 and 1 in 1,000 risk reductions, respectively, from wave 1 and wave 2. The corresponding U.S. figures
are 22.0 and 37.7 percent. 19
expect that, when a formal estimate of mean WTP is obtained, WTP for the two risk reductions
will be found to be significantly different.
Estimates of median and mean annual WTP based on equation (1) without using
covariates are reported in Table 7.
6,7  We exclude from our models those respondents who failed
both the initial probability test and probability choice questions described above, whether or not
they subsequently corrected their answers (FLAG1=1). 
                                                          
6 All figures are expressed in US dollars, based on a purchasing power parity for 1.25 US dollars per
Canadian dollar.
7 Mean WTP is computed as  ) 1 ˆ / 1 ( ˆ + Γ ⋅θ σ , and median WTP is 
θ σ
/ 1 ) 5 . 0 ln (− ⋅  where the hats denote
the use of the estimates. The compute standard errors around mean WTP, we drew samples of 20000
observations from a multivariate normal distribution centered on the estimated Weibull parameters and
with covariate matrix equal to the inverse of the information matrix of log likelihood (1). We use the values
drawn from this distribution to compute 20000 estimates of mean WTP. The standard deviation of this
vector of artificially generated mean WTP values is the standard error of the estimate of mean WTP shown
in table 8. 20
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Percent of "yes" responses by bid value: 
US study21
We estimate mean WTP for the 5 in 1,000 risk reduction from wave 1 of the Canada
sample to be $466 (U.S. dollars), with a standard error around the mean of $33.6. Wave 2 of the
Canada sample holds a mean WTP value of $370, with a standard error of $48.6.
8 A Wald test
indicates that these two mean WTP figures are marginally statistically different (Wald statistic
2.65; p-value = 0.10), only just satisfying the so-called “scope test.”  Mean WTP, however, is not
strictly proportional to the size of the risk reduction. The ratio of the mean WTP figures is 1.3,
and not 5, and a Wald test clearly rejects the hypothesis of proportionality to the size of the risk
reduction (Wald statistic 32.0, p-value < 0.0001). 
A similar story holds for the U.S. sample.  The mean WTP for the 5 in 1,000 risk change
of $770 (s.e. $86.9) is statistically different from the mean WTP for the 1 in 1,000 risk reduction
                                                          
8 The estimates reported in table 7 are based on excluding from the sample failed both the initial probability
test question and the probability choice question. We experimented with many other criteria for excluding
respondents from the usable sample based on their explicit or stated poor comprehension of probability, but
found that mean WTP changed very little. 
Table 7.
Mean and Median WTP for Reduced Mortality Risk  (U.S. dollars*)
Canada U.S.
Median WTP Mean WTP Median WTP Mean WTP




























Are the WTP Figures for Risk Reductions of Different Sizes…
Significantly different? Yes Yes Yes Yes
•  Wald Test 23.74 2.65 56.10 6.32
•  p-value <0.0001 0.10 <0.0001 0.01










•  Wald Test 19.0 32.0 7.3 18.7
•  p-value < 0.0001 < 0.0001 0.007 < 0.0001
Notes: Standard errors in parentheses. Estimates based on cleaned data (respondents with FLAG1=1
deleted). Sample from the U.S. excludes people older than 80 years of age.
* In U.S. dollars, using purchasing power parity of $1.25 Canadian per $1 US.22
of $483 (s.e. $74.0), with the Wald statistic equal to 6.32 (p=0.01).  Once again the null
hypothesis of proportionality of mean WTP with the size of the risk change is soundly rejected
(Wald statistic 18.7, p-value < 0.0001).
Holding the risk reduction the same, the WTP figures for the Canada sample do not differ
appreciably from the U.S. figures.  The Wald statistics are 0.17 (p-value 0.67) for the 5 in 1,000
risk reduction, and 1.05 (p-value 0.30) for the smaller risk change.
Median WTP estimates are also reported in Table 7. While median WTP increases
significantly with the size of the risk reduction, satisfying the scope test, the median WTP figures
do not exhibit strict proportionality with size of the risk reduction. The ratio between the median
WTP values for the two risk reduction, however, is greater than that for the mean WTP figures
(1.9 in Canada and 3.2 in the US).
In Table 8, we examine the effects of respondent confidence on median WTP estimates.
After querying respondents regarding their WTP for each risk reduction, we asked respondents to
indicate the level of certainty they had in their responses on a scale from 1 to 7.  This table is
based on grouping respondents by how confident they felt about their WTP responses,
categorizing certainty levels of 6 and 7 as “high confidence” and all other certainty levels as “low
confidence.” 
As before, regardless of the stated degree of confidence expressed by the respondent,
WTP estimates for the risk reductions of different magnitudes remained statistically significantly
different, with the WTP for the large risk reduction substantially larger than that for the small
reduction. Interestingly, when attention is restricted to those respondents who reported a high
degree of certainty, the median WTP estimates for the two risk reductions are near-proportional.
The ratio between the median WTP amounts is 1.99 for Canada and 8.99 for the US, and both
figures are not statistically different from 5.
The estimates of implied Value of a Statistical Life (VSL) are displayed in Table 9.
These are calculated using the mean annual WTP (from Table 7), and dividing it by the annual 23
risk reduction implied by the product/action described to the respondent.
9 Given the similarity of
the WTP figures from the Canada and U.S. studies, it is not surprising that the VSLs are also very
similar across the two studies.  
                                                          
9  Assuming that the respondents spread the risk reduction evenly over the 10 years, this approach
overcomes the difficulty of having to choose a discount rate for the 10 annual payments.  
Table 8.
The Effect of Confidence on Median WTP for Reductions to Mortality Risk
(U.S.$)







































Are the WTP Figures for Risk Reductions of Different Sizes…
Significantly different? Yes Yes Yes Yes
•  Wald Test 25.95 9.51 18.04 22.48
•  p-value <0.0001 0.002 <0.0001 <0.0001
Proportional to the size









•  Wald Test 1.99 11.8 2.04 31.21
•  p-value 0.15 0.0006 0.15 <0.0001
Note: Standard errors in parentheses. Estimates based on cleaned data (respondents with FLAG1=1
deleted; respondents older than 80 excluded).
Table 9.













5 in 1,000 506,000 933,000 700,000 1,540,000
1 in 1,000 1,312,000 3,704,000 1,110,000 4,830,000
Note:  VSLs computed using on annual risk changes, i.e. 5 in 10,000 and 1 in 10,00024
The VSL estimates for Canada range from $506,000 and $933,000, when computed using
WTP for the 5 in 1,000 risk reduction, compared to $700,000 and $1.54 million for the U.S.
When based on WTP for the 1 in 1,000 risk reduction, the VSL estimates climb, reaching
upwards of $4 million.  Because WTP is generally not proportional to the size of the risk change,
VSL estimates are larger when calculated using WTP for the smaller risk change.   While the
more generous VSL amounts for Canada appear in line with estimates used in policy assessments
affecting elderly populations, they are well below the estimates used by US EPA in its recent
policy analyses.
B. WTP, Age, Health and Income
In this section, we examine the relationship between WTP, age, health, and income.  To
motivate our analysis and the selection of the independent variables to be included in the
regression models, we reason that the life-cycle model predicts that WTP at age j to reduce one’s
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where d is the probability of dying during period j,  t j, π   is the probability of surviving until
period t, given that one is alive at j, u is the utility function, and Xt is consumption in period t
(Cropper and Sussman, 1990). 
According to equation (2), age influences WTP in two possible ways.  First, it affects the
future probabilities of survival (with and without the risk reduction).  It may, in addition,
influence the rate at which individuals trade off income for the probability of survival—in other
words, the last term of (2). 
In the policy debate, it is sometimes argued that VSL should be adjusted for age.
Specifically, some observers note that if the lives of the people saved by the policy are those of
older people, these people should be assigned a lower VSL because of their shorter remaining25
life. This is akin to focusing to the sum of the future survival probabilities, π, which decreases
with current age j.  This reasoning, however, ignores the possibility of increasing marginal values
for future years of life.
Under certain assumptions, and for specified values of the parameters entering in the
utility function, economic theory predicts that WTP should first rise and then decline with age
(Shepard and Zeckhauser, 1982).
Similar considerations hold for individual health status.  The baseline risks should be
higher for people in poor health, and some observers argue that people in poor health value less
increased probabilities of survival (or each additional year of life) if survival implies poor quality
of life.  On the other hand, health can influence the rate at which people tradeoff income for
longevity, implying that the net effect of (age and) health on WTP is an empirical issue.
We present results of interval-data Weibull regressions of WTP on several individual
characteristics, including age and health, in Table 10 for the 5 in 1,000 risk reduction based on
wave 1 for both the U.S. and Canadian samples.  The Weibull regressions posit that
θ β
/ 1
0 ) exp( WTP x WTP i = , where WTP0 is WTP when all covariates are set to zero, which is
distributed as a Weibull with shape parameter θ and scale 1. A log transformation produces the
equation  ε θ β ) / 1 ( log 1 + = x WTP , where  0 logWTP = ε  follows the type I extreme value
distribution. This is, effectively, an accelerated life model.
In the first specification, as shown in table 10, we formed dummies denoting whether the
respondent fell in the 50 to 59 age group, 60 to 69, and 70 and older.  When these dummies are
included in the right-hand side of the Weibull model, the coefficients of the age 50-59 and 60-69
age group dummies are indistinguishable from that of the 40-49 age bracket (captured by the
intercept). The coefficient of the oldest age bracket, however, is significantly lower for the
Canada sample. This remains true when other covariates are included in the regression.  No age
effects were found using the U.S. sample.26
Table 10. Weibull Interval-Data Regression Results for Canada and U.S.
(Standard Errors in Parentheses)
Canada U.S.
Variable Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
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Note: ** indicates significance at the 5% level; * indicates significance at the 10% level. FLAG1=1
deleted. U.S. sample only includes people of ages no greater than 80 years.27
Based on these results, we ran a parsimonious regression model that includes the
intercept and a dummy variable taking on a value of one if the respondent is 70 years of age or
older.  The results are reported in Table 11.  Median WTP for respondents is $262 (U.S. dollars)
for Canadian respondents of ages 40 to 69 years, and drops by approximately 25 percent to $201
for respondents of ages 70 years and older.  These two median WTP values are statistically
different at the 5 percent level.   In comparison, median WTP for U.S. respondents aged 70 years
and older was only about 20 percent lower than that for the younger age group. This difference,
however, did not prove to be statistically significant.  We conclude that the impact of age on
WTP is modest, and that the adjustment of VSL for age has limited empirical support. 
Regarding respondent health, we experimented with all available measures of health
status.  The relationship between physical health status and WTP differs across the two studies.
In the Canada sample, for instance, the only health effect of import appears to be cancer.
Respondents so affected had a median WTP (reported in table 11) equal to $510 (U.S. dollars),
compared to $308 for a person without cancer.  Care is necessary when interpreting these results,
however, because only a very small portion of the total Canadian sample has or has had cancer
(26 respondents).  Furthermore, these people were well enough to travel to the facility to take the
survey, and may therefore not be representative of cancer patients or survivors in the population. 
In the U.S. study, on the other hand, although persons with a cancer history were more
numerous, their WTP was not different from that of other respondents.  Instead, it was histories of
chronic lung disease and high blood pressure that had a statistically significantly effect on
willingness to pay values.  Interestingly, however, the effects of health history on WTP do not
withstand the inclusion of variables controlling for the respondents’ acceptance or understanding
of the scenarios presented.  
More important than respondent health in either sample, it appears, is family history of
chronic illness.  In both samples, family history of chronic illness other than cancer (among28
parents and/or siblings) was statistically significant at the 5 percent level in both specifications in
which they were included.
Table 11.
Median WTP for Respondents of Specified Ages and Health Status.*
(U.S. dollars, Standard errors in parentheses)
Characteristic CANADA U.S.




























































*  Respondents with FLAG1=1 deleted.
** Definition of chronic: (for Canada) respondent has one or more of the following: asthma,
emphysema, high blood pressure, heart disease, or cancer; (for the U.S.) respondent has one or more of
the following: asthma, emphysema, chronic bronchitis, any of the CARDIO conditions, or cancer.
*** Definition of CARDIO: respondent has one or more of the following: angina pectoris, coronary
disease, other heart diseases, and/or has had a myocardial infarction.29
E. WTP for future risk reductions
Our last research question investigates the amount people are willing to pay for specified
risk reductions with the payment beginning immediately but with the risk reduction incurred in
the future.  Of the three commodities faced by respondents in the survey, this is the one most
representative of the type of risk reduction resulting from environmental policy.  We report WTP
for this future risk reduction in Table 12 below.  The table shows that both mean and median
WTP values for the future risk reduction are lower than WTP estimates for an immediate risk
reduction of comparable size.  This result holds regardless of the age of the respondent at the time
of the immediate risk reduction.  
It is important to note, however, that, in all interviews with respondents less than 60 years
of age, this future risk scenario was the last the respondent faced. We combined the two waves of
data, after checking that WTP for the future risk reduction did not vary across the two waves due
to possible order/sequencing effects. 
It is also important to note that, because of the placement of the future risk questions, it is
impossible to conduct an external scope test that would show, across respondents, that future risk
reductions are valued less than immediate ones of the same size.  
VI. Conclusions and Implications for Policy
Traditional estimates of the willingness-to-pay for mortality risk reductions are seldom
conditioned on the age and health status of the respondent. Our survey is designed to provide
credible estimates of such values that are applicable to mortality risk reductions associated with
environmental policy.  These values could also be used in benefit-cost analyses of programs that
primarily benefit older persons, many of whom may be in poor health.
We find that for persons aged 40 and older sampled using random digit dialing
techniques in Hamilton, Ontario, and in the U.S., WTP for risk reductions varies significantly
with the size of the reduction.  Mean WTP for an annual reduction in risk of death of 5 in 10,00030
is about 1.5 times WTP for an annual risk reduction of 1 in 10,000 (1.3 for Canada and 1.6 for the
U.S.).  WTP is, therefore, sensitive to the size of the risk reduction, but not strictly proportional to
it.  WTP values are very similar across the two samples, and translate into values of a statistical
life of approximately $4,830,000 for a 1 in 10,000 annual risk reduction and $930,000 for a 5 in
10,000 annual risk reduction.
We find that WTP does not vary much by age up to 70.  Mean WTP for the 5 in 1,000
risk change remains approximately constant age until about age 70, decreasing by about one-third
thereafter.  This latter WTP is probably the most relevant one for use in valuing most of the lives
“saved” from air pollution reductions. The effect is significant in Canada but not in the U.S.
study.
Regardless of the measure of physical health status used (with few exceptions), WTP
does not vary appreciably with physical health status either—an important result for
environmental policy, since older people and people with chronic conditions are often the
beneficiaries of improvements in environmental quality.  We do, however, find that in the Canada
Table 12. Willingness to Pay for a Risk Reduction Beginning at Age 70
(U.S. dollars, standard errors in parentheses)
Canada U.S.




























Risk reduction of same size
starting immediately










Risk reduction of same size
starting immediately
(ages 70 and over; wave 1)
N=67 N=161
Note:  Results based on cleaned data -- respondents with FLAG1=1 were excluded. Only
respondents aged less than 65 years were asked about risk reductions beginning at age 70.31
study individuals with cancer are WTP over 60 percent more for a mortality risk reduction than
their counterparts without cancer. By contrast, individuals in the U.S. study are willing to pay
more for the risk reduction if they have a heart ailment.
These results stand in sharp contrast to the way in which age and health status are treated
in evaluating medical interventions.  We believe the comparison is relevant, since it is sometimes
suggested that a similar approach be used in benefit-cost analyses of health and safety regulations
(Food and Drug Administration, 1999). The standard approach in the medical literature is to
measure life-saving benefits in terms of Quality Adjusted Life Years Saved (QALYs).  This
assumes that the value of lives saved is strictly proportional to remaining life expectancy, and that
the value of saving a life-year is less for a person with a chronic disease, such as chronic
bronchitis, than for a healthy person, with the exact equivalence determined by QALY weights.
Our results do not support either of these assumptions.  There is no evidence that the VSL should
be equally apportioned over remaining life expectancy, or that the VSL is systematically lower
for persons with chronic illness.32
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